Загрузка...
Canagliflozin: Efficacy and Safety in Combination with Metformin Alone or with Other Antihyperglycemic Agents in Type 2 Diabetes
Metformin is typically the first pharmacologic treatment recommended for type 2 diabetes mellitus (T2DM), but many patients do not achieve glycemic control with metformin alone and eventually require combination therapy with other agents. Canagliflozin, a sodium glucose co-transporter 2 (SGLT2) inhi...
Сохранить в:
| Опубликовано в: : | Diabetes Ther |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer Healthcare
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5118239/ https://ncbi.nlm.nih.gov/pubmed/27734320 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-016-0201-z |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|